ClinConnect ClinConnect Logo
Search / Trial NCT05458323

Cognitive Level Enhancement Through Vision Exams and Refraction

Launched by QUEEN'S UNIVERSITY, BELFAST · Jul 11, 2022

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

Cognitive Decline Elderly Refractive Error Spectacles Cost Effectiveness Analysis Dementia

ClinConnect Summary

This clinical trial is looking at how providing free glasses to older adults in Hyderabad, India, can improve their overall quality of life. Specifically, the study is focused on people aged 60 and older who have vision problems due to refractive errors, which means their eyesight could be improved with the right glasses. The researchers want to see if giving these glasses can help reduce falls, depression, and improve social interactions and physical activity over a three-year period. Participants will be randomly assigned to either receive the glasses or not, while also providing information about their experiences and the cultural context of the study.

To be eligible, participants need to live in the community, plan to stay in the area for the duration of the study, and have specific vision impairments that could be corrected with glasses. They should also have good cognitive function, meaning their thinking and memory skills are intact. Those with serious health issues or other causes of vision impairment won't be included. If chosen for the trial, participants can expect to wear the glasses and share their experiences, which will help researchers understand the impact of better vision on their daily lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria
  • 1. Community dwelling
  • 2. Residency
  • a. Participants must plan to reside in the local area for the study duration
  • 3. Presenting vision in the better eye due to uncorrected refractive error
  • 1. Impaired distance vision less than 6/18
  • 2. Near vision less than N6 at 40 cm
  • 4. Willingness
  • 1. to participate
  • 2. to be randomized
  • 3. to adhere to the protocol
  • Exclusion criteria
  • 1. Impaired baseline cognition
  • a. HMSE score less than or equal to 18
  • 2. Non-refractive causes of vision impairment
  • 3. Severely impaired mobility
  • 1. immobile
  • 2. bedridden
  • 3. wheelchair
  • 4. using walker
  • 4. Severe medical illness likely to limit the life span
  • 1. Cancer
  • 2. Heart disease
  • 3. Stroke
  • 4. HIV or AIDS
  • 5. Chronic lung disease
  • 6. Kidney disease
  • 5. Hearing loss assessment
  • 1. self-reported hearing impairment
  • 2. inability to hear
  • 3. fail in whisper test hearing screening(unable to repeat three out of six words)

About Queen's University, Belfast

Queen's University Belfast is a prestigious research institution located in Northern Ireland, renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical research. The university actively engages in a diverse range of clinical trials, focusing on translational medicine and interdisciplinary collaboration to address pressing health challenges. With a strong emphasis on ethical standards and patient safety, Queen's University Belfast leverages its state-of-the-art facilities and a team of experienced researchers to contribute to the development of new therapies and enhance the understanding of various medical conditions.

Locations

Hyderabad, Telangana, India

Patients applied

0 patients applied

Trial Officials

Nathan G Congdon, MD, MPH

Principal Investigator

Queen's University, Belfast

Rohit C Khanna, MPH

Principal Investigator

L.V. Prasad Eye Institute

Suvarna Alladi, DM

Principal Investigator

National Institute of Mental Health and Neuro Sciences, India

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials